Intelligence

Start-up hopes to boost production of viral vectors for ATMPs
#AAV #Advanced Therapy Medicinal Products (ATMPs) #Cell and gene therapy #Seed funding #Start-ups

Start-up hopes to boost production of viral vectors for ATMPs

New South African company NewBiologix has launched with the aim of developing a proprietary and breakthrough platform for the advanced engineering of cell lines used to manufacture gene and cell therapies. The company’s DNA-based platform is being developed to address manufacturing challenges associated with the production… Read More

#News #Start-up Zone

AI brain
#AI / data analytics / healthtech / informatics #Drug discovery #Funding #MultiOmic Health #Precision medicine #Seed funding #Start-ups

AI platform focuses on precision medicines for metabolic syndromes

AI drug discovery company MultiOmic Health has closed a £5 million ($6.2 million) seed funding extension round to build a precision therapeutics discovery platform for metabolic syndrome-related medical conditions. The round was led by London-based Hoxton Ventures, with participation from Ada Ventures, MMC Ventures and Verve… Read More

#News #Start-up Zone

#Biosimilars #IQVIA #Market reporting #United States

US drugs market grows by 5% in 2022

The US market for medicines grew by 5% in 2022, reaching a total value of $429Bn on a net price basis. This was driven by a range of factors, including an increase in health services utilisation, which is now back to pre-pandemic levels, and the entry… Read More

#Editor's Choice #Market Reports #News

#Drug development #Drug discovery #Emulate #Organ-on-a-chip

An introduction to organ-on-a-chip technology

Download Emulate’s Introduction to Organ-on-a-Chip Technology eBook to learn about: What Organ-Chips are, how they work, and why they are transforming the way drugs are discovered and developed How Organ-Chips overcome the main challenges of conventional in vivo and in vitro models The wide variety of insights and endpoint analyses… Read More

#Resources

#BioIndustry Association #Biotechnology #Clarivate #Funding #Investment #Private investment #UK

UK biotech sector raised £295 million in first quarter of 2023

The first quarter of 2023 has seen deal flow continue for UK life science and biotech companies at all stages of development, new data from the UK BioIndustry Association and Clarivate shows. As global macro-economic headwinds, suppressed public markets and political uncertainty weighed on investor confidence,… Read More

#Business & Investment #Market Reports #News

#DNA #Drug discovery #INTEGRA #Laboratory #PCR

How to become a PCR pro

The term ‘PCR’ has been on everybody’s lips since the outbreak of the Covid-19 pandemic, but only laboratory professionals know how difficult it can be to achieve success with this well-established technique. If your PCR reactions are driving you to despair, look no further than INTEGRA’s comprehensive eBook! Learn more… Read More

#Resources

#Agilent #Biosafety testing #Drug discovery #In vivo #Infographic #Mitochondria

Learn new ways to identify mitochondrial liability

Download our mitochondrial toxicity infographic and discover the benefits of novel in vitro strategies for consumer safety. Drug-induced mitochondrial dysfunction has been linked to compound attrition, organ toxicity, black-box warnings, and market withdrawals. Our infographic will help you: Gain an historical perspective on mitochondrial toxicity. Understand the importance of testing… Read More

#Intelligence #Resources

#BioInnovation Institute #Drug discovery #Funding #Investment #Start-ups

Global start-ups: where is the innovation?

Listen to this article on the DDW Podcast: DDW takes a look at some key global activity taking place around the world for drug discovery and life sciences start-ups. UK Budget a ‘shot in the arm’ for oncology start-ups Before the UK announced… Read More

#Exclusive Content #Start-up Zone

#App note #Cell culture #Human disease models #In vivo #Live cell analysis #Sartorius

Kinetically quantify neuronal outgrowth using live-cell analysis

Monitoring neuronal morphology in long-term in vitro cell cultures is critical for characterisation and evaluation of disease models and to understand neuronal development. Ideally, approaches to track neurite dynamics would allow continuous automated measurements of structural parameters, including neurite length and number of branch points. These methods should be non-perturbing… Read More

#App Notes #Intelligence #Resources

Proteomics
#Genetics / genomics #Mass spectrometry / NMR #Nautilus #Oncology #Protein chemistry / Proteomics #Rare cancers

Democratising proteomics for cancer and beyond

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong speaks to Nautilus Co-Founder and Chief Scientist Parag Mallick, about the company’s recent collaboration which aims to uncover the proteins that could be behind a rare and fatal childhood cancer. At… Read More

#Exclusive Content #Trends & Analysis

#Antibodies #Antibody-based therapeutics #Bio-Rad Laboratories #In Focus Report #Monoclonal antibodies

The future of antibody based drugs: Where are the opportunities?

This report will:   Provide an overview of the monoclonal antibody (mAbs) industry: market value, key on the future of antibody-based drug players, opportunities and the future  Explore what’s next for antibody-based drugs and where the opportunity is coming from  Include an interview Bio-Rad’s… Read More

#DDW eBooks #Intelligence

#Cell culture #Drug development #Drug discovery #Guide #iPSC

Four cell culture hacks to get the best out of your neurons

Make your iPSC-derived glutamatergic neuron cultures a success every time with these tips from a neuronal cell culture expert. In this Guide, you will learn: How to prevent glutamatergic neurons from detaching from culture surfaces How to formulate extracellular matrix coatings to promote cell adherence The best timings for media… Read More

#Intelligence #Resources

Hyderabad
#Biotech hubs #Drug discovery hotspots #India #Life sciences #Pharmaceuticals

Drug discovery hotspots: India’s Genome Valley

Could India become an important centre of drug discovery innovation? Diana Spencer explores the evolution of the Hyderabad life sciences hub. India is traditionally known as ‘the pharmacy of the world’ due to its huge pharmaceuticals manufacturing capacity and high quantity of exports, particularly generic medicines… Read More

#Exclusive Content #Market Reports

Computer in laboratory
#Cancer research #Funding #Investment #Mosaic Therapeutics #Oncology #Wellcome Sanger Institute

Company raises $28m to develop targeted cancer therapies

Mosaic Therapeutics has closed its $28 million series A funding round and appointed former Novartis Oncology SVP Brian Gladsden as CEO. The Series A funding will be used to further advance Mosaic’s pipeline of targeted oncology therapies for biomarker-stratified populations, progressing its lead programmes through preclinical… Read More

#Business & Investment #Cancer Research #News #Start-up Zone